Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca D Santomasso

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Continuum (Minneapolis, Minn.)|June 4, 2020
Anticancer Drugs and the Nervous SystemBianca D Santomasso
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Neurotoxicity Biology and ManagementHusain Danish, Bianca D Santomasso
Blood|March 6, 2023
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicityBianca D Santomasso, Juliane Gust, Fabiana Perna
Blood|September 3, 2024
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapyXavier Deschênes-Simard, Bianca D Santomasso, Parastoo B Dahi
CNS Oncology|June 8, 2022
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecanNelson S Moss, Umberto Tosi, Bianca D Santomasso, et al.
Blood|November 4, 2022
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cellsAdam Goldman, Emanuel Raschi, Joab Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Ophthalmology|August 3, 2020
ReplyJasmine H Francis, Korey Jaben, Bianca D Santomasso, et al.
Scientific Reports|November 23, 2024
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapyDavid Mao, Anne S Reiner, Xi Chen, et al.
Ophthalmology|May 22, 2020
Immune Checkpoint Inhibitor-Associated Optic NeuritisJasmine H Francis, Korey Jaben, Bianca D Santomasso, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Continuum (Minneapolis, Minn.)|June 4, 2020
Anticancer Drugs and the Nervous SystemBianca D Santomasso
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Neurotoxicity Biology and ManagementHusain Danish, Bianca D Santomasso
Blood|March 6, 2023
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicityBianca D Santomasso, Juliane Gust, Fabiana Perna
Blood|September 3, 2024
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapyXavier Deschênes-Simard, Bianca D Santomasso, Parastoo B Dahi
CNS Oncology|June 8, 2022
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecanNelson S Moss, Umberto Tosi, Bianca D Santomasso, et al.
Blood|November 4, 2022
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cellsAdam Goldman, Emanuel Raschi, Joab Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Ophthalmology|August 3, 2020
ReplyJasmine H Francis, Korey Jaben, Bianca D Santomasso, et al.
Scientific Reports|November 23, 2024
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapyDavid Mao, Anne S Reiner, Xi Chen, et al.
Ophthalmology|May 22, 2020
Immune Checkpoint Inhibitor-Associated Optic NeuritisJasmine H Francis, Korey Jaben, Bianca D Santomasso, et al.
Pageof 5